Last checked at | Tuesday 12 May |
| GLI Finance |
| Macfarlane Group |
| IWG |
| Standard Life Aberdeen |
| HgCapital Trust |
| Reckitt Benckiser |
| Fidelity European Values |
| Wednesday 13 May |
| Ultra Electronics |
| Vesuvius |
| Sanne Group |
| Dialight |
| Gym Group |
| Tritax Big Box REIT |
| Robert Walters |
| Foxtons Group |
| Spirax-Sarco Engineering |
| Greggs |
| TP ICAP |
| Rentokil Initial |
| Cineworld Group |
| Marshalls |
| Xeros Technology (re bid offer) |
| Thursday 14 May |
| Safestyle UK |
| Serco |
| Direct Line |
| Next |
| Computacenter |
| Prudential |
| Quilter |
| Just Eat Takeaway.com |
| Gresham Technology |
| Flutter Entertainment |
| Spire Healthcare Group |
| Telit Communications |
| Genel Energy |
| Cairn energy |
| Forterra |
| Triple Point Social Housing REIT |
| Horizonte Minerals |
| European Assets Trust |
| Eurocell |
| TI Fluid System |
| Friday 15 May |
| Gresham House |
| William Hill |
| Phoenix Group |
| Petrofac |
| Bank of Ireland Group |
| Serinus Energy |
| Signature Aviation |
| Derwent London |
| Monday 18 May |
| Alliance Pharma |
| Faron Pharmaceuticals |
| Bank of Georgia |
| Alcentra European Floating Rate Income Fund |
| Copyright 2020 Alliance News Limited. All Rights Reserved. |
14 Jun 2019 11:54
Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial
(Alliance News) - Faron Pharmaceuticals Oy on Friday said analysis of a more recent trial of Traumakine has explained why the drug did not perform as expected in a previous trial.Shares in
Read more